Skip to main content

Table 1 Comparisons of demographic data and pre- and peri-operative clinical features based on hospital mortality in liver transplantation patients

From: Association between surgical volumes and hospital mortality in patients: a living donor liver transplantation single center experience

Demographic and clinical features No hospital mortality (n = 433) Hospital mortality (n = 30) p
Mean ± SD (range) Mean ± SD (range)
Recipient age (years) 54.08 ± 8.41 (11–73) 52.43 ± 11.66 (21–73) 0.453
Donor age (years) 31.12 ± 9.15 (18.0–65.00) 35.27 ± 9.28 (20.0–56.00) 0.017
MELD score 17.59 ± 9.31 (3.0–40.0) 23.33 ± 9.32 (9.0–37.0) < 0.001
Total bilirubin (mg/dL) 6.89 ± 9.62 (0.19–47.69) 8.75 ± 10.33 (0.32–38.68) 0.314
Creatinine (mg/dL) 1.16 ± 0.96 (0.32–8.65) 1.55 ± 1.10 (0.40–4.90) 0.075
INR 1.53 ± 0.638 (0.87–4.76) 1.69 ± 0.62 (0.95–3.64) 0.201
GRWR 1.10 ± 0.30 (0.55–2.28) 1.13 ± 0.33 (0.68–2.04) 0.617
Blood loss (ml) 3478.10 ± 3656.62 (300.0–39,450.0) 7003.00 ± 7371.99 (200.0–40,000.0) 0.014
Operative time (min) 408.79 ± 93.87 (215.00–855.00) 434.33 ± 105.65 (280.00–660.00) 0.154
  (%) (%)  
Gender    0.859
 Male 338 (78.1) 23 (76.7)  
 Female 95 (21.9) 7 (23.3)  
The type of disease    0.087
 Alcoholic ± viruses 108(24.9) 13(43.3)  
 Virus related 284(65.6) 13(43.3)  
 Primary biliary cholangitis 8(1.8) 1(3.3)  
 Other 33(7.6) 3(10.0)  
Pre-LT renal failure    0.197
 Yes 21 (4.8) 3 (10.0)  
 No 412 (93.8) 27 (90.0)  
Pre-LT in intensive care unit    0.001
 Yes 27 (6.2) 7 (23.3)  
 No 406 (93.8) 23 (76.7)  
ABO incompatible 1.000   
 Yes 51 (11.8) 3 (10.0)  
 No 382 (88.2) 27 (90.0)  
Liver transplant cases/year    
 < 20/year 17 (3.9) 2 (6.7) 0.353
 ≥ 20/year 416 (96.1) 28 (93.3)  
 < 30/year 65 (15.0) 9 (30.0) 0.030
 ≥ 30/year 368 (85.0) 21 (70.0)  
 < 50/year 135 (31.2) 14 (46.7) 0.079
 ≥ 50/year 298 (68.8) 16 (53.3)  
  1. Model for end-stage liver disease (MELD) score, international normalized ratio (INR), graft-recipient weight ratio (GRWR), liver transplantation (LT). The types of disease were alcoholic (n = 102, 22.0%), alcoholic ± hepatitis B or C (n = 19, 4.1%), hepatitis B (n = 165, 35.6%), hepatitis C (n = 110, 23.8%), hepatitis B and C (n = 22, 4.8%), primary biliary cholangitis (n = 9, 1.9%) and other (n = 36, 7.8%): non-hepatitis B and C (n = 25), autoimmune (n = 6), drug toxicity (n = 1), liver tumor (n = 4)